This paper examines by state variation in drug prices and drug spending. Variation in prices are found to be minimal but variation in spending (and utilization) are more substantial. Further work will explore the underlying reasons for the spending variation and whether patterns persist when analyzed for areas other than states.
Prescription Drugs
Reports
Displaying 61 - 70 of 77. 10 per page. Page 7.
Advanced SearchIssues in the Design and Implementation of Drug Formularies and Therapeutic Classes
As part of the Medicare Part D pharmacy benefit scheduled for implementation in 2006 by the Medicare Prescription Drug, Improvement, and Modernization Act (MMA), beneficiaries will have a choice of private plans administering the benefit.? Although plans are required to provide access to needed drugs, the law does not require plans to provide equal coverage for all drugs.?
Developing A Risk Adjustment Methodology for Medicare Drug Plans
This paper describes the work NORC did to supplement the Federal Employee Health Benefits data (FEHBP) used to develop drug risk adjustment factors for over 65 individuals with a full drug supplement to Medicare. This data needed to be supplemented because the FEHBP data did not adequately represent, low-income, disabled, or non east Coast populations.
Options for Defining Medicare Advantage Regions: An Assessment of Trade-offs
The Secretary of the Department of Health and Human Services (HHS) was charged with setting regional market areas for the implementation of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA).
Medication Use in Long-Term Care Facilities and Community Settings for Medicare Beneficiaries with Cardiovascular Disease
This report compares medication use in long-term care facilities and community settings for Medicare beneficiaries with heart conditions. The purpose of this comparison was to evaluate the utility of a new file of institutional drug use in the Medicare Current Beneficiary Survey (MCBS), the premier source of health care information on the Medicare population.
The Contribution of Medication Use to Recent Trends in Old-Age Functioning
U.S. Department of Health and Human Services
Securing the Benefits of Medical Innovation for Seniors: The Role of Prescription Drugs and Drug Coverage
This report examines the consequences to medical innovation and overall health posed by attempts to contain drug expenditures by implementing government controls.
The Effects of Congressional Proposals on Prescription Drug Costs for Medicare Beneficiaries
Department of Health and Human Services Office of the Assistant Secretary for Public Affairs Provides discussion and estimates of several Congressional proposals on prescription drug costs for Medicare beneficiaries.